Tiba wins BARDA contract to develop RNA bird flu vaccine – Fierce Biotech

The $749999 contract will see Tiba Biotech build on previous work to develop new a RNA-based vaccine against the H1N1 strain of the bird flu.

Read More at Source.

Pumilo
Author: Pumilo